OpenVSafe by OpenVAERS
Search V-safe

2WF-26027-74769

3 vaccinations 1 coded response 27 check-ins 1 free-text entry 2 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
558 / MN
Registered
2020-12-26
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-26
    Registered in v-safe
  2. 2020-12-26
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-26
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  4. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Chills, Fatigue or tiredness, Nausea
    Adult check-in
  5. 2020-12-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  6. 2020-12-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Diarrhea
    Adult check-in
  8. 2020-12-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-02
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-09
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-01-16
    Dose 2 — Pfizer-BioNTech
  13. 2021-01-16
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  14. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-01-17
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  16. 2021-01-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  17. 2021-01-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  18. 2021-01-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  19. 2021-01-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  20. 2021-01-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  21. 2021-01-23
    Health check-in — day 7, dose 2
    Feeling: Good · Headache
    Adult check-in
  22. 2021-01-30
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-06
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-02-13
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-02-20
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-02-27
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-04-17
    Survey response — 3 months, dose 2
    MedDRA: Gestational diabetes — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Gestational diabetes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  28. 2021-04-17
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  29. 2021-04-28
  30. 2021-07-19
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  31. 2021-10-09
    Dose 3 — Pfizer-BioNTech
  32. 2022-01-22
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  33. 2022-04-12
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  34. 2022-10-09
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-26Pfizer-BioNTech
22021-01-16Pfizer-BioNTech
32021-10-09Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-01-17 Unsuccessful
2021-04-17 Unsuccessful

Free text

Release 7 — 3 months, dose 2

2021-04-17

Symptoms: Gestational diabetes

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDGestational diabetes ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…